(Q107073639)

1

0 references

Thomas W. M. Crozier

2

0 references

Edward J. D. Greenwood

3

0 references

Paul J. Lehner

4

0 references

Gavin J. Wright

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

5

0 references

publication date

11 January 2021

0 references

published in

Scientific Reports

0 references

volume

11

0 references

issue

1

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038/S41598-020-80464-1

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

2 June 2021

1 reference

https://api.crossref.org/works/10.1038/S41598-020-80464-1

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

2 June 2021

1 reference

https://api.crossref.org/works/10.1038/S41598-020-80464-1

Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 Is an Important Surface Attachment Factor That Facilitates Entry of Middle East Respiratory Syndrome Coronavirus

2 June 2021

1 reference

https://api.crossref.org/works/10.1038/S41598-020-80464-1

Middle East respiratory syndrome coronavirus and bat coronavirus HKU9 both can utilize GRP78 for attachment onto host cells

2 June 2021

1 reference

https://api.crossref.org/works/10.1038/S41598-020-80464-1

CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus

2 June 2021

1 reference

https://api.crossref.org/works/10.1038/S41598-020-80464-1

DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus

2 June 2021

1 reference

https://api.crossref.org/works/10.1038/S41598-020-80464-1

SARS-CoV-2 invades host cells via a novel route: CD147-spike protein

2 June 2021

1 reference

https://api.crossref.org/works/10.1038/S41598-020-80464-1

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

2 June 2021

1 reference

https://api.crossref.org/works/10.1038/S41598-020-80464-1

Meplazumab treats COVID-19 pneumonia: an open-labelled, concurrent controlled add-on clinical trial

2 June 2021

1 reference

https://api.crossref.org/works/10.1038/S41598-020-80464-1

Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparum

2 June 2021

1 reference

https://api.crossref.org/works/10.1038/S41598-020-80464-1

Basigin is a druggable target for host-oriented antimalarial interventions

2 June 2021

1 reference

https://api.crossref.org/works/10.1038/S41598-020-80464-1

Cyclophilin A and CD147: novel therapeutic targets for the treatment of COVID-19

2 June 2021

1 reference

https://api.crossref.org/works/10.1038/S41598-020-80464-1

Distribution of ACE2, CD147, CD26 and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors

2 June 2021

1 reference

https://api.crossref.org/works/10.1038/S41598-020-80464-1

Gene expression and in situ protein profiling of candidate SARS-CoV-2 receptors in human airway epithelial cells and lung tissue

2 June 2021

1 reference

https://api.crossref.org/works/10.1038/S41598-020-80464-1

Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2

2 June 2021

1 reference

https://api.crossref.org/works/10.1038/S41598-020-80464-1

Approaches to identify extracellular receptor–ligand interactions

2 June 2021

1 reference

https://api.crossref.org/works/10.1038/S41598-020-80464-1

TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes

2 June 2021

1 reference

https://api.crossref.org/works/10.1038/S41598-020-80464-1

Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV

2 June 2021

1 reference

https://api.crossref.org/works/10.1038/S41598-020-80464-1

SARS-CoV-2 and SARS-CoV differ in their cell tropism and drug sensitivity profiles

2 June 2021

1 reference

https://api.crossref.org/works/10.1038/S41598-020-80464-1

Resurrection of the ancestral RH5 invasion ligand provides a molecular explanation for the origin of P. falciparum malaria in humans

2 June 2021

1 reference

https://api.crossref.org/works/10.1038/S41598-020-80464-1

RH5-Basigin interaction plays a major role in the host tropism of Plasmodium falciparum.

2 June 2021

1 reference

https://api.crossref.org/works/10.1038/S41598-020-80464-1

T cell activation-associated epitopes of CD147 in regulation of the T cell response, and their definition by antibody affinity and antigen density

2 June 2021

1 reference

https://api.crossref.org/works/10.1038/S41598-020-80464-1

Dose-Response Analysis Using R.

2 June 2021

1 reference

https://api.crossref.org/works/10.1038/S41598-020-80464-1

Alpha-v-containing integrins are host receptors for the sporozoite surface protein, TRAP

2 June 2021

1 reference

https://api.crossref.org/works/10.1038/S41598-020-80464-1

Large-scale screening for novel low-affinity extracellular protein interactions

2 June 2021

1 reference

https://api.crossref.org/works/10.1038/S41598-020-80464-1

Lymphoid/neuronal cell surface OX2 glycoprotein recognizes a novel receptor on macrophages implicated in the control of their function

2 June 2021

1 reference

https://api.crossref.org/works/10.1038/S41598-020-80464-1

Spike mutation pipeline reveals the emergence of a more transmissible form of SARS-CoV-2

2 June 2021

1 reference

https://api.crossref.org/works/10.1038/S41598-020-80464-1

Unveiling diffusion pattern and structural impact of the most invasive SARS-CoV-2 spike mutation

2 June 2021

1 reference

https://api.crossref.org/works/10.1038/S41598-020-80464-1

Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study

2 June 2021

1 reference

https://api.crossref.org/works/10.1038/S41598-020-80464-1

The sterol-responsive RNF145 E3 ubiquitin ligase mediates the degradation of HMG-CoA reductase together with gp78 and Hrd1

2 June 2021

1 reference

https://api.crossref.org/works/10.1038/S41598-020-80464-1

Neuropilin-1 is a host factor for SARS-CoV-2 infection

2 June 2021

1 reference

https://api.crossref.org/works/10.1038/S41598-020-80464-1

COVID-19 spike-host cell receptor GRP78 binding site prediction

2 June 2021

1 reference

https://api.crossref.org/works/10.1038/S41598-020-80464-1

Proteomic Profiling in Biracial Cohorts Implicates DC-SIGN as a Mediator of Genetic Risk in COVID-19

2 June 2021

1 reference

https://api.crossref.org/works/10.1038/S41598-020-80464-1

The MERS-CoV receptor DPP4 as a candidate binding target of the SARS-CoV-2 spike

2 June 2021

1 reference

https://api.crossref.org/works/10.1038/S41598-020-80464-1

CD147 as a Target for COVID-19 Treatment: Suggested Effects of Azithromycin and Stem Cell Engagement

2 June 2021

1 reference

https://api.crossref.org/works/10.1038/S41598-020-80464-1

Potential Therapeutic Targets and Promising Drugs for Combating SARS-CoV-2

2 June 2021

1 reference

https://api.crossref.org/works/10.1038/S41598-020-80464-1

Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence

2 June 2021

1 reference

https://api.crossref.org/works/10.1038/S41598-020-80464-1

Is COVID-19 a New Hematologic Disease?

2 June 2021

1 reference

https://api.crossref.org/works/10.1038/S41598-020-80464-1

Molecular basis of the potential interaction of SARS-CoV-2 spike protein to CD147 in COVID-19 associated-lymphopenia

2 June 2021

1 reference

https://api.crossref.org/works/10.1038/S41598-020-80464-1

ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities

2 June 2021

1 reference

https://api.crossref.org/works/10.1038/S41598-020-80464-1

Basigin (CD147), a multifunctional transmembrane glycoprotein with various binding partners

2 June 2021

1 reference

https://api.crossref.org/works/10.1038/S41598-020-80464-1

Virological assessment of hospitalized patients with COVID-2019

2 June 2021

1 reference

https://api.crossref.org/works/10.1038/S41598-020-80464-1

IL-6: relevance for immunopathology of SARS-CoV-2

2 June 2021

1 reference

https://api.crossref.org/works/10.1038/S41598-020-80464-1

Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)?

2 June 2021

1 reference

https://api.crossref.org/works/10.1038/S41598-020-80464-1

COVID-19 and Genetic Variants of Protein Involved in the SARS-CoV-2 Entry into the Host Cells

2 June 2021

1 reference

https://api.crossref.org/works/10.1038/S41598-020-80464-1

Important functional roles of basigin in thymocyte development and T cell activation

2 June 2021

1 reference

https://api.crossref.org/works/10.1038/S41598-020-80464-1

Longitudinal analyses reveal immunological misfiring in severe COVID-19

2 June 2021

1 reference

https://api.crossref.org/works/10.1038/S41598-020-80464-1

CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression

2 June 2021

1 reference

https://api.crossref.org/works/10.1038/S41598-020-80464-1

A rapid and scalable method for selecting recombinant mouse monoclonal antibodies

2 June 2021

1 reference

https://api.crossref.org/works/10.1038/S41598-020-80464-1

A benchmarked protein microarray-based platform for the identification of novel low-affinity extracellular protein interactions

2 June 2021

1 reference

https://api.crossref.org/works/10.1038/S41598-020-80464-1

Avidity-based extracellular interaction screening (AVEXIS) for the scalable detection of low-affinity extracellular receptor-ligand interactions

2 June 2021

1 reference

https://api.crossref.org/works/10.1038/S41598-020-80464-1

Metabolic biotinylation of secreted and cell surface proteins from mammalian cells

2 June 2021

1 reference

https://api.crossref.org/works/10.1038/S41598-020-80464-1

Optimizing high-yield production of SARS-CoV-2 soluble spike trimers for serology assays

2 June 2021

1 reference

https://api.crossref.org/works/10.1038/S41598-020-80464-1

Methods of inactivation of SARS-CoV-2 for downstream biological assays

2 June 2021

1 reference

https://api.crossref.org/works/10.1038/S41598-020-80464-1

CytoML for cross-platform cytometry data sharing.

2 June 2021

1 reference

https://api.crossref.org/works/10.1038/S41598-020-80464-1